context
stringlengths 21
24.6k
| category
stringclasses 2
values | entity
stringlengths 1
12
| entity_type
stringclasses 5
values | query
stringlengths 97
3.31k
| answer
stringlengths 12
168
|
|---|---|---|---|---|---|
As of December 31, 2023, the Company had $ 75 million in borrowings under these facilities, which are reported in Short-term borrowings and current portion of long-term debt on the Consolidated Balance Sheets. The Company utilized its committed revolving credit facility for short-term working capital requirements. As of December 31, 2024, the Company had no outstanding borrowings under the Revolving Facility, and availability of $ 499 million. | text | 499 | monetaryItemType | text: <entity> 499 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, the Company had $ 75 million in borrowings under these facilities, which are reported in Short-term borrowings and current portion of long-term debt on the Consolidated Balance Sheets. The Company utilized its committed revolving credit facility for short-term working capital requirements. As of December 31, 2024, the Company had no outstanding borrowings under the Revolving Facility, and availability of $ 499 million. </context> | us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity |
On April 4, 2024, the Company issued $ 525 million aggregate principal amount of 6.75 % Senior Secured Notes due 2029 (the 2029 Notes) pursuant to an indenture among the Company, as issuer, certain subsidiaries of the Company named as guarantors, and U.S. Bank Trust Company, National Association, as trustee and collateral agent. The 2029 Notes were sold to investors at 100 % plus accrued interest, if any, from April 4, 2024 in a private transaction exempt from the registration requirements of the Securities Act. The net proceeds of the offering of the 2029 Notes were used to repay all of the Company’s outstanding borrowings and accrued interest under the Term Loan B Facility and the Revolving Facility and to pay fees and expenses in connection with the offering. During the second quarter of 2024, the Company recorded a non-cash pre-tax loss on extinguishment of $ 20 million related to the difference between the repayment amount and net carrying amount of the Term Loan B Facility, which is included in the Interest expense line item on the Consolidated Statements of Operations. | text | 525 | monetaryItemType | text: <entity> 525 </entity> <entity type> monetaryItemType </entity type> <context> On April 4, 2024, the Company issued $ 525 million aggregate principal amount of 6.75 % Senior Secured Notes due 2029 (the 2029 Notes) pursuant to an indenture among the Company, as issuer, certain subsidiaries of the Company named as guarantors, and U.S. Bank Trust Company, National Association, as trustee and collateral agent. The 2029 Notes were sold to investors at 100 % plus accrued interest, if any, from April 4, 2024 in a private transaction exempt from the registration requirements of the Securities Act. The net proceeds of the offering of the 2029 Notes were used to repay all of the Company’s outstanding borrowings and accrued interest under the Term Loan B Facility and the Revolving Facility and to pay fees and expenses in connection with the offering. During the second quarter of 2024, the Company recorded a non-cash pre-tax loss on extinguishment of $ 20 million related to the difference between the repayment amount and net carrying amount of the Term Loan B Facility, which is included in the Interest expense line item on the Consolidated Statements of Operations. </context> | us-gaap:DebtInstrumentFaceAmount |
On April 4, 2024, the Company issued $ 525 million aggregate principal amount of 6.75 % Senior Secured Notes due 2029 (the 2029 Notes) pursuant to an indenture among the Company, as issuer, certain subsidiaries of the Company named as guarantors, and U.S. Bank Trust Company, National Association, as trustee and collateral agent. The 2029 Notes were sold to investors at 100 % plus accrued interest, if any, from April 4, 2024 in a private transaction exempt from the registration requirements of the Securities Act. The net proceeds of the offering of the 2029 Notes were used to repay all of the Company’s outstanding borrowings and accrued interest under the Term Loan B Facility and the Revolving Facility and to pay fees and expenses in connection with the offering. During the second quarter of 2024, the Company recorded a non-cash pre-tax loss on extinguishment of $ 20 million related to the difference between the repayment amount and net carrying amount of the Term Loan B Facility, which is included in the Interest expense line item on the Consolidated Statements of Operations. | text | 6.75 | percentItemType | text: <entity> 6.75 </entity> <entity type> percentItemType </entity type> <context> On April 4, 2024, the Company issued $ 525 million aggregate principal amount of 6.75 % Senior Secured Notes due 2029 (the 2029 Notes) pursuant to an indenture among the Company, as issuer, certain subsidiaries of the Company named as guarantors, and U.S. Bank Trust Company, National Association, as trustee and collateral agent. The 2029 Notes were sold to investors at 100 % plus accrued interest, if any, from April 4, 2024 in a private transaction exempt from the registration requirements of the Securities Act. The net proceeds of the offering of the 2029 Notes were used to repay all of the Company’s outstanding borrowings and accrued interest under the Term Loan B Facility and the Revolving Facility and to pay fees and expenses in connection with the offering. During the second quarter of 2024, the Company recorded a non-cash pre-tax loss on extinguishment of $ 20 million related to the difference between the repayment amount and net carrying amount of the Term Loan B Facility, which is included in the Interest expense line item on the Consolidated Statements of Operations. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
On April 4, 2024, the Company issued $ 525 million aggregate principal amount of 6.75 % Senior Secured Notes due 2029 (the 2029 Notes) pursuant to an indenture among the Company, as issuer, certain subsidiaries of the Company named as guarantors, and U.S. Bank Trust Company, National Association, as trustee and collateral agent. The 2029 Notes were sold to investors at 100 % plus accrued interest, if any, from April 4, 2024 in a private transaction exempt from the registration requirements of the Securities Act. The net proceeds of the offering of the 2029 Notes were used to repay all of the Company’s outstanding borrowings and accrued interest under the Term Loan B Facility and the Revolving Facility and to pay fees and expenses in connection with the offering. During the second quarter of 2024, the Company recorded a non-cash pre-tax loss on extinguishment of $ 20 million related to the difference between the repayment amount and net carrying amount of the Term Loan B Facility, which is included in the Interest expense line item on the Consolidated Statements of Operations. | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> On April 4, 2024, the Company issued $ 525 million aggregate principal amount of 6.75 % Senior Secured Notes due 2029 (the 2029 Notes) pursuant to an indenture among the Company, as issuer, certain subsidiaries of the Company named as guarantors, and U.S. Bank Trust Company, National Association, as trustee and collateral agent. The 2029 Notes were sold to investors at 100 % plus accrued interest, if any, from April 4, 2024 in a private transaction exempt from the registration requirements of the Securities Act. The net proceeds of the offering of the 2029 Notes were used to repay all of the Company’s outstanding borrowings and accrued interest under the Term Loan B Facility and the Revolving Facility and to pay fees and expenses in connection with the offering. During the second quarter of 2024, the Company recorded a non-cash pre-tax loss on extinguishment of $ 20 million related to the difference between the repayment amount and net carrying amount of the Term Loan B Facility, which is included in the Interest expense line item on the Consolidated Statements of Operations. </context> | us-gaap:LongTermDebtPercentageBearingFixedInterestRate |
On April 4, 2024, the Company issued $ 525 million aggregate principal amount of 6.75 % Senior Secured Notes due 2029 (the 2029 Notes) pursuant to an indenture among the Company, as issuer, certain subsidiaries of the Company named as guarantors, and U.S. Bank Trust Company, National Association, as trustee and collateral agent. The 2029 Notes were sold to investors at 100 % plus accrued interest, if any, from April 4, 2024 in a private transaction exempt from the registration requirements of the Securities Act. The net proceeds of the offering of the 2029 Notes were used to repay all of the Company’s outstanding borrowings and accrued interest under the Term Loan B Facility and the Revolving Facility and to pay fees and expenses in connection with the offering. During the second quarter of 2024, the Company recorded a non-cash pre-tax loss on extinguishment of $ 20 million related to the difference between the repayment amount and net carrying amount of the Term Loan B Facility, which is included in the Interest expense line item on the Consolidated Statements of Operations. | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> On April 4, 2024, the Company issued $ 525 million aggregate principal amount of 6.75 % Senior Secured Notes due 2029 (the 2029 Notes) pursuant to an indenture among the Company, as issuer, certain subsidiaries of the Company named as guarantors, and U.S. Bank Trust Company, National Association, as trustee and collateral agent. The 2029 Notes were sold to investors at 100 % plus accrued interest, if any, from April 4, 2024 in a private transaction exempt from the registration requirements of the Securities Act. The net proceeds of the offering of the 2029 Notes were used to repay all of the Company’s outstanding borrowings and accrued interest under the Term Loan B Facility and the Revolving Facility and to pay fees and expenses in connection with the offering. During the second quarter of 2024, the Company recorded a non-cash pre-tax loss on extinguishment of $ 20 million related to the difference between the repayment amount and net carrying amount of the Term Loan B Facility, which is included in the Interest expense line item on the Consolidated Statements of Operations. </context> | us-gaap:GainsLossesOnExtinguishmentOfDebt |
The 2029 Notes bear interest at a rate of 6.75 % per annum. Interest on the 2029 Notes is payable semiannually on April 15 and October 15 of each year, commencing on October 15, 2024. The 2029 Notes will mature on April 15, 2029. | text | 6.75 | percentItemType | text: <entity> 6.75 </entity> <entity type> percentItemType </entity type> <context> The 2029 Notes bear interest at a rate of 6.75 % per annum. Interest on the 2029 Notes is payable semiannually on April 15 and October 15 of each year, commencing on October 15, 2024. The 2029 Notes will mature on April 15, 2029. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
The 2029 Notes are senior secured obligations of the Company and are jointly and severally, fully and unconditionally, guaranteed on a senior secured basis by certain of the Company’s existing and future direct and indirect domestic restricted subsidiaries that incur or guarantee indebtedness under the Facilities or other qualifying indebtedness that, in the aggregate, exceeds $ 25 million, including the 2032 Notes (as defined below). The 2029 Notes and the guarantees are secured by a first-priority security interest in substantially all of the Company’s and the guarantors’ assets, subject to certain excluded assets, exceptions and permitted liens, which security interest ranks equally with the first-priority security interest securing the Facilities. | text | 25 | monetaryItemType | text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> The 2029 Notes are senior secured obligations of the Company and are jointly and severally, fully and unconditionally, guaranteed on a senior secured basis by certain of the Company’s existing and future direct and indirect domestic restricted subsidiaries that incur or guarantee indebtedness under the Facilities or other qualifying indebtedness that, in the aggregate, exceeds $ 25 million, including the 2032 Notes (as defined below). The 2029 Notes and the guarantees are secured by a first-priority security interest in substantially all of the Company’s and the guarantors’ assets, subject to certain excluded assets, exceptions and permitted liens, which security interest ranks equally with the first-priority security interest securing the Facilities. </context> | us-gaap:DebtInstrumentFaceAmount |
On September 17, 2024, the Company issued $ 450 million aggregate principal amount of 6.625 % Senior Notes due 2032 (the 2032 Notes) pursuant to an indenture among the Company, as issuer, certain subsidiaries of the Company named as guarantors, and U.S. Bank Trust Company, National Association, as trustee. The 2032 Notes were sold to investors at 100 % plus accrued interest, if any, from September 17, 2024 in a private transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the Securities Act). The net proceeds of the offering of the 2032 Notes were used to repay all of the Company’s outstanding borrowings under the Term Loan A Facility, to pay fees and expenses in connection with the offering, and for general corporate purposes. During the third quarter of 2024, the Company recorded a non-cash pre-tax loss on extinguishment of $ 2 million related to the difference between the repayment amount and net carrying amount of the Term Loan A Facility, which is included in the Interest expense line item on the Consolidated Statements of Operations. | text | 450 | monetaryItemType | text: <entity> 450 </entity> <entity type> monetaryItemType </entity type> <context> On September 17, 2024, the Company issued $ 450 million aggregate principal amount of 6.625 % Senior Notes due 2032 (the 2032 Notes) pursuant to an indenture among the Company, as issuer, certain subsidiaries of the Company named as guarantors, and U.S. Bank Trust Company, National Association, as trustee. The 2032 Notes were sold to investors at 100 % plus accrued interest, if any, from September 17, 2024 in a private transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the Securities Act). The net proceeds of the offering of the 2032 Notes were used to repay all of the Company’s outstanding borrowings under the Term Loan A Facility, to pay fees and expenses in connection with the offering, and for general corporate purposes. During the third quarter of 2024, the Company recorded a non-cash pre-tax loss on extinguishment of $ 2 million related to the difference between the repayment amount and net carrying amount of the Term Loan A Facility, which is included in the Interest expense line item on the Consolidated Statements of Operations. </context> | us-gaap:DebtInstrumentFaceAmount |
On September 17, 2024, the Company issued $ 450 million aggregate principal amount of 6.625 % Senior Notes due 2032 (the 2032 Notes) pursuant to an indenture among the Company, as issuer, certain subsidiaries of the Company named as guarantors, and U.S. Bank Trust Company, National Association, as trustee. The 2032 Notes were sold to investors at 100 % plus accrued interest, if any, from September 17, 2024 in a private transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the Securities Act). The net proceeds of the offering of the 2032 Notes were used to repay all of the Company’s outstanding borrowings under the Term Loan A Facility, to pay fees and expenses in connection with the offering, and for general corporate purposes. During the third quarter of 2024, the Company recorded a non-cash pre-tax loss on extinguishment of $ 2 million related to the difference between the repayment amount and net carrying amount of the Term Loan A Facility, which is included in the Interest expense line item on the Consolidated Statements of Operations. | text | 6.625 | percentItemType | text: <entity> 6.625 </entity> <entity type> percentItemType </entity type> <context> On September 17, 2024, the Company issued $ 450 million aggregate principal amount of 6.625 % Senior Notes due 2032 (the 2032 Notes) pursuant to an indenture among the Company, as issuer, certain subsidiaries of the Company named as guarantors, and U.S. Bank Trust Company, National Association, as trustee. The 2032 Notes were sold to investors at 100 % plus accrued interest, if any, from September 17, 2024 in a private transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the Securities Act). The net proceeds of the offering of the 2032 Notes were used to repay all of the Company’s outstanding borrowings under the Term Loan A Facility, to pay fees and expenses in connection with the offering, and for general corporate purposes. During the third quarter of 2024, the Company recorded a non-cash pre-tax loss on extinguishment of $ 2 million related to the difference between the repayment amount and net carrying amount of the Term Loan A Facility, which is included in the Interest expense line item on the Consolidated Statements of Operations. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
On September 17, 2024, the Company issued $ 450 million aggregate principal amount of 6.625 % Senior Notes due 2032 (the 2032 Notes) pursuant to an indenture among the Company, as issuer, certain subsidiaries of the Company named as guarantors, and U.S. Bank Trust Company, National Association, as trustee. The 2032 Notes were sold to investors at 100 % plus accrued interest, if any, from September 17, 2024 in a private transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the Securities Act). The net proceeds of the offering of the 2032 Notes were used to repay all of the Company’s outstanding borrowings under the Term Loan A Facility, to pay fees and expenses in connection with the offering, and for general corporate purposes. During the third quarter of 2024, the Company recorded a non-cash pre-tax loss on extinguishment of $ 2 million related to the difference between the repayment amount and net carrying amount of the Term Loan A Facility, which is included in the Interest expense line item on the Consolidated Statements of Operations. | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> On September 17, 2024, the Company issued $ 450 million aggregate principal amount of 6.625 % Senior Notes due 2032 (the 2032 Notes) pursuant to an indenture among the Company, as issuer, certain subsidiaries of the Company named as guarantors, and U.S. Bank Trust Company, National Association, as trustee. The 2032 Notes were sold to investors at 100 % plus accrued interest, if any, from September 17, 2024 in a private transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the Securities Act). The net proceeds of the offering of the 2032 Notes were used to repay all of the Company’s outstanding borrowings under the Term Loan A Facility, to pay fees and expenses in connection with the offering, and for general corporate purposes. During the third quarter of 2024, the Company recorded a non-cash pre-tax loss on extinguishment of $ 2 million related to the difference between the repayment amount and net carrying amount of the Term Loan A Facility, which is included in the Interest expense line item on the Consolidated Statements of Operations. </context> | us-gaap:LongTermDebtPercentageBearingFixedInterestRate |
On September 17, 2024, the Company issued $ 450 million aggregate principal amount of 6.625 % Senior Notes due 2032 (the 2032 Notes) pursuant to an indenture among the Company, as issuer, certain subsidiaries of the Company named as guarantors, and U.S. Bank Trust Company, National Association, as trustee. The 2032 Notes were sold to investors at 100 % plus accrued interest, if any, from September 17, 2024 in a private transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the Securities Act). The net proceeds of the offering of the 2032 Notes were used to repay all of the Company’s outstanding borrowings under the Term Loan A Facility, to pay fees and expenses in connection with the offering, and for general corporate purposes. During the third quarter of 2024, the Company recorded a non-cash pre-tax loss on extinguishment of $ 2 million related to the difference between the repayment amount and net carrying amount of the Term Loan A Facility, which is included in the Interest expense line item on the Consolidated Statements of Operations. | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> On September 17, 2024, the Company issued $ 450 million aggregate principal amount of 6.625 % Senior Notes due 2032 (the 2032 Notes) pursuant to an indenture among the Company, as issuer, certain subsidiaries of the Company named as guarantors, and U.S. Bank Trust Company, National Association, as trustee. The 2032 Notes were sold to investors at 100 % plus accrued interest, if any, from September 17, 2024 in a private transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the Securities Act). The net proceeds of the offering of the 2032 Notes were used to repay all of the Company’s outstanding borrowings under the Term Loan A Facility, to pay fees and expenses in connection with the offering, and for general corporate purposes. During the third quarter of 2024, the Company recorded a non-cash pre-tax loss on extinguishment of $ 2 million related to the difference between the repayment amount and net carrying amount of the Term Loan A Facility, which is included in the Interest expense line item on the Consolidated Statements of Operations. </context> | us-gaap:GainsLossesOnExtinguishmentOfDebt |
The 2032 Notes bear interest at a rate of 6.625 % per annum. Interest on the 2032 Notes is payable semiannually on April 15 and October 15 of each year, commencing on April 15, 2025. The 2032 Notes will mature on October 15, 2032. | text | 6.625 | percentItemType | text: <entity> 6.625 </entity> <entity type> percentItemType </entity type> <context> The 2032 Notes bear interest at a rate of 6.625 % per annum. Interest on the 2032 Notes is payable semiannually on April 15 and October 15 of each year, commencing on April 15, 2025. The 2032 Notes will mature on October 15, 2032. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The 2032 Notes are senior unsecured obligations of the Company and are jointly and severally, fully and unconditionally, guaranteed on a senior unsecured basis by certain of the Company’s existing and future direct and indirect domestic restricted subsidiaries that incur or guarantee indebtedness under the Facilities or other qualifying indebtedness that, in the aggregate, exceeds $ 25 million, including the 2029 Notes. | text | 25 | monetaryItemType | text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> The 2032 Notes are senior unsecured obligations of the Company and are jointly and severally, fully and unconditionally, guaranteed on a senior unsecured basis by certain of the Company’s existing and future direct and indirect domestic restricted subsidiaries that incur or guarantee indebtedness under the Facilities or other qualifying indebtedness that, in the aggregate, exceeds $ 25 million, including the 2029 Notes. </context> | us-gaap:DebtInstrumentFaceAmount |
In 2020, the Former Parent completed its acquisition of Delphi Technologies PLC (Delphi Technologies). In connection therewith, the Former Parent completed its offer to exchange Delphi Technologies’ outstanding 5.0 % Senior Notes due 2025 (the 2025 Notes). Approximately 97 % of the $ 800 million total outstanding principal amount | text | 5.0 | percentItemType | text: <entity> 5.0 </entity> <entity type> percentItemType </entity type> <context> In 2020, the Former Parent completed its acquisition of Delphi Technologies PLC (Delphi Technologies). In connection therewith, the Former Parent completed its offer to exchange Delphi Technologies’ outstanding 5.0 % Senior Notes due 2025 (the 2025 Notes). Approximately 97 % of the $ 800 million total outstanding principal amount </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
In 2020, the Former Parent completed its acquisition of Delphi Technologies PLC (Delphi Technologies). In connection therewith, the Former Parent completed its offer to exchange Delphi Technologies’ outstanding 5.0 % Senior Notes due 2025 (the 2025 Notes). Approximately 97 % of the $ 800 million total outstanding principal amount | text | 800 | monetaryItemType | text: <entity> 800 </entity> <entity type> monetaryItemType </entity type> <context> In 2020, the Former Parent completed its acquisition of Delphi Technologies PLC (Delphi Technologies). In connection therewith, the Former Parent completed its offer to exchange Delphi Technologies’ outstanding 5.0 % Senior Notes due 2025 (the 2025 Notes). Approximately 97 % of the $ 800 million total outstanding principal amount </context> | us-gaap:DebtInstrumentCarryingAmount |
As of December 31, 2024, the estimated fair values of the Company’s long-term debt totaled $ 1,007 million, which is $ 21 million higher than carrying value for the same period. As of December 31, 2023, the estimated fair value of the Company’s long-term debt totaled $ 758 million, which was $ 35 million higher than carrying value for the same period. Fair market values of the long-term debt are developed using observable values for similar debt instruments, which are considered Level 2 inputs as defined by ASC Topic 820. The carrying values of the Company’s other debt facilities approximate fair value. The fair value estimates do not necessarily reflect the values the Company could realize in the current markets. | text | 1007 | monetaryItemType | text: <entity> 1007 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the estimated fair values of the Company’s long-term debt totaled $ 1,007 million, which is $ 21 million higher than carrying value for the same period. As of December 31, 2023, the estimated fair value of the Company’s long-term debt totaled $ 758 million, which was $ 35 million higher than carrying value for the same period. Fair market values of the long-term debt are developed using observable values for similar debt instruments, which are considered Level 2 inputs as defined by ASC Topic 820. The carrying values of the Company’s other debt facilities approximate fair value. The fair value estimates do not necessarily reflect the values the Company could realize in the current markets. </context> | us-gaap:DebtInstrumentFairValue |
As of December 31, 2024, the estimated fair values of the Company’s long-term debt totaled $ 1,007 million, which is $ 21 million higher than carrying value for the same period. As of December 31, 2023, the estimated fair value of the Company’s long-term debt totaled $ 758 million, which was $ 35 million higher than carrying value for the same period. Fair market values of the long-term debt are developed using observable values for similar debt instruments, which are considered Level 2 inputs as defined by ASC Topic 820. The carrying values of the Company’s other debt facilities approximate fair value. The fair value estimates do not necessarily reflect the values the Company could realize in the current markets. | text | 758 | monetaryItemType | text: <entity> 758 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the estimated fair values of the Company’s long-term debt totaled $ 1,007 million, which is $ 21 million higher than carrying value for the same period. As of December 31, 2023, the estimated fair value of the Company’s long-term debt totaled $ 758 million, which was $ 35 million higher than carrying value for the same period. Fair market values of the long-term debt are developed using observable values for similar debt instruments, which are considered Level 2 inputs as defined by ASC Topic 820. The carrying values of the Company’s other debt facilities approximate fair value. The fair value estimates do not necessarily reflect the values the Company could realize in the current markets. </context> | us-gaap:DebtInstrumentFairValue |
As of December 31, 2024, the United States dollar equivalent notional values of outstanding currency derivative instruments used for foreign currency cash flow hedging was $ 85 million. These amounts were primarily related to Euro denominated forward contracts at British Pound functional currency locations. As of December 31, 2023, there were no outstanding currency derivative instruments. At December 31, 2024 and | text | 85 | monetaryItemType | text: <entity> 85 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the United States dollar equivalent notional values of outstanding currency derivative instruments used for foreign currency cash flow hedging was $ 85 million. These amounts were primarily related to Euro denominated forward contracts at British Pound functional currency locations. As of December 31, 2023, there were no outstanding currency derivative instruments. At December 31, 2024 and </context> | us-gaap:DerivativeNotionalAmount |
Derivative instruments designated as hedging instruments as defined by ASC Topic 815 recognized in Other comprehensive income for the years ended December 31, 2024, 2023, and 2022 were a loss of $ 0 million, a loss of $ 3 million, and a gain of $ 5 million, respectively. No material gains or losses were recorded in Net earnings for the periods presented. | text | 0 | monetaryItemType | text: <entity> 0 </entity> <entity type> monetaryItemType </entity type> <context> Derivative instruments designated as hedging instruments as defined by ASC Topic 815 recognized in Other comprehensive income for the years ended December 31, 2024, 2023, and 2022 were a loss of $ 0 million, a loss of $ 3 million, and a gain of $ 5 million, respectively. No material gains or losses were recorded in Net earnings for the periods presented. </context> | us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax |
Derivative instruments designated as hedging instruments as defined by ASC Topic 815 recognized in Other comprehensive income for the years ended December 31, 2024, 2023, and 2022 were a loss of $ 0 million, a loss of $ 3 million, and a gain of $ 5 million, respectively. No material gains or losses were recorded in Net earnings for the periods presented. | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> Derivative instruments designated as hedging instruments as defined by ASC Topic 815 recognized in Other comprehensive income for the years ended December 31, 2024, 2023, and 2022 were a loss of $ 0 million, a loss of $ 3 million, and a gain of $ 5 million, respectively. No material gains or losses were recorded in Net earnings for the periods presented. </context> | us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax |
Derivative instruments designated as hedging instruments as defined by ASC Topic 815 recognized in Other comprehensive income for the years ended December 31, 2024, 2023, and 2022 were a loss of $ 0 million, a loss of $ 3 million, and a gain of $ 5 million, respectively. No material gains or losses were recorded in Net earnings for the periods presented. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> Derivative instruments designated as hedging instruments as defined by ASC Topic 815 recognized in Other comprehensive income for the years ended December 31, 2024, 2023, and 2022 were a loss of $ 0 million, a loss of $ 3 million, and a gain of $ 5 million, respectively. No material gains or losses were recorded in Net earnings for the periods presented. </context> | us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax |
The Company expects to contribute a total of $ 5 million to $ 9 million into its defined benefit pension plans during 2025. Of the $ 5 million to $ 9 million in projected 2025 contributions, $ 2 million are contractually obligated, while any remaining payments would be discretionary. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> The Company expects to contribute a total of $ 5 million to $ 9 million into its defined benefit pension plans during 2025. Of the $ 5 million to $ 9 million in projected 2025 contributions, $ 2 million are contractually obligated, while any remaining payments would be discretionary. </context> | us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear |
The Company expects to contribute a total of $ 5 million to $ 9 million into its defined benefit pension plans during 2025. Of the $ 5 million to $ 9 million in projected 2025 contributions, $ 2 million are contractually obligated, while any remaining payments would be discretionary. | text | 9 | monetaryItemType | text: <entity> 9 </entity> <entity type> monetaryItemType </entity type> <context> The Company expects to contribute a total of $ 5 million to $ 9 million into its defined benefit pension plans during 2025. Of the $ 5 million to $ 9 million in projected 2025 contributions, $ 2 million are contractually obligated, while any remaining payments would be discretionary. </context> | us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear |
Includes 5.61 % and 4.62 % for the U.K. pension plans for December 31, 2024 and 2023, respectively. | text | 5.61 | percentItemType | text: <entity> 5.61 </entity> <entity type> percentItemType </entity type> <context> Includes 5.61 % and 4.62 % for the U.K. pension plans for December 31, 2024 and 2023, respectively. </context> | us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate |
Includes 5.61 % and 4.62 % for the U.K. pension plans for December 31, 2024 and 2023, respectively. | text | 4.62 | percentItemType | text: <entity> 4.62 </entity> <entity type> percentItemType </entity type> <context> Includes 5.61 % and 4.62 % for the U.K. pension plans for December 31, 2024 and 2023, respectively. </context> | us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate |
Includes 4.62 %, 4.93 % and 1.81 % for the U.K. pension plans for December 31, 2024, 2023 and 2022, respectively. | text | 4.62 | percentItemType | text: <entity> 4.62 </entity> <entity type> percentItemType </entity type> <context> Includes 4.62 %, 4.93 % and 1.81 % for the U.K. pension plans for December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate |
Includes 4.62 %, 4.93 % and 1.81 % for the U.K. pension plans for December 31, 2024, 2023 and 2022, respectively. | text | 4.93 | percentItemType | text: <entity> 4.93 </entity> <entity type> percentItemType </entity type> <context> Includes 4.62 %, 4.93 % and 1.81 % for the U.K. pension plans for December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate |
Includes 4.62 %, 4.93 % and 1.81 % for the U.K. pension plans for December 31, 2024, 2023 and 2022, respectively. | text | 1.81 | percentItemType | text: <entity> 1.81 </entity> <entity type> percentItemType </entity type> <context> Includes 4.62 %, 4.93 % and 1.81 % for the U.K. pension plans for December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate |
Includes 5.25 %, 5.50 % and 4.18 % for the U.K. pension plans for December 31, 2024, 2023 and 2022, respectively. | text | 5.25 | percentItemType | text: <entity> 5.25 </entity> <entity type> percentItemType </entity type> <context> Includes 5.25 %, 5.50 % and 4.18 % for the U.K. pension plans for December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate |
Includes 5.25 %, 5.50 % and 4.18 % for the U.K. pension plans for December 31, 2024, 2023 and 2022, respectively. | text | 5.50 | percentItemType | text: <entity> 5.50 </entity> <entity type> percentItemType </entity type> <context> Includes 5.25 %, 5.50 % and 4.18 % for the U.K. pension plans for December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate |
Includes 5.25 %, 5.50 % and 4.18 % for the U.K. pension plans for December 31, 2024, 2023 and 2022, respectively. | text | 4.18 | percentItemType | text: <entity> 4.18 </entity> <entity type> percentItemType </entity type> <context> Includes 5.25 %, 5.50 % and 4.18 % for the U.K. pension plans for December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostWeightedAverageInterestCreditingRate |
The Company has granted restricted common stock and restricted stock units (collectively, “restricted stock”) and performance stock units as long-term incentive awards to employees and non-employee directors under the PHINIA Inc. 2023 Stock Incentive Plan (2023 Plan). The Company’s Board of Directors adopted the 2023 Plan in July 2023. The 2023 Plan authorizes the issuance of a total of 4.7 million shares. Approximately 3.6 million shares were available for future issuance as of December 31, 2024. | text | 4.7 | sharesItemType | text: <entity> 4.7 </entity> <entity type> sharesItemType </entity type> <context> The Company has granted restricted common stock and restricted stock units (collectively, “restricted stock”) and performance stock units as long-term incentive awards to employees and non-employee directors under the PHINIA Inc. 2023 Stock Incentive Plan (2023 Plan). The Company’s Board of Directors adopted the 2023 Plan in July 2023. The 2023 Plan authorizes the issuance of a total of 4.7 million shares. Approximately 3.6 million shares were available for future issuance as of December 31, 2024. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
The Company has granted restricted common stock and restricted stock units (collectively, “restricted stock”) and performance stock units as long-term incentive awards to employees and non-employee directors under the PHINIA Inc. 2023 Stock Incentive Plan (2023 Plan). The Company’s Board of Directors adopted the 2023 Plan in July 2023. The 2023 Plan authorizes the issuance of a total of 4.7 million shares. Approximately 3.6 million shares were available for future issuance as of December 31, 2024. | text | 3.6 | sharesItemType | text: <entity> 3.6 </entity> <entity type> sharesItemType </entity type> <context> The Company has granted restricted common stock and restricted stock units (collectively, “restricted stock”) and performance stock units as long-term incentive awards to employees and non-employee directors under the PHINIA Inc. 2023 Stock Incentive Plan (2023 Plan). The Company’s Board of Directors adopted the 2023 Plan in July 2023. The 2023 Plan authorizes the issuance of a total of 4.7 million shares. Approximately 3.6 million shares were available for future issuance as of December 31, 2024. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
In connection with the Spin-Off, outstanding equity awards to employees under the 2018 Plan were replaced with PHINIA equity awards using a formula designed to maintain the economic value of the awards immediately before and after the Spin-Off. Accordingly, the number of restricted stock underlying each unvested award outstanding as of the date of the Spin-Off was multiplied by a factor of 1.74 , which resulted in no increase in the intrinsic value of awards outstanding. The replaced restricted stock awards continue to vest in accordance with their original vesting period. These replacement awards did not result in additional compensation expense to the Company. | text | no | perShareItemType | text: <entity> no </entity> <entity type> perShareItemType </entity type> <context> In connection with the Spin-Off, outstanding equity awards to employees under the 2018 Plan were replaced with PHINIA equity awards using a formula designed to maintain the economic value of the awards immediately before and after the Spin-Off. Accordingly, the number of restricted stock underlying each unvested award outstanding as of the date of the Spin-Off was multiplied by a factor of 1.74 , which resulted in no increase in the intrinsic value of awards outstanding. The replaced restricted stock awards continue to vest in accordance with their original vesting period. These replacement awards did not result in additional compensation expense to the Company. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue |
The value of restricted stock is determined by the market value of the Company’s common stock at the date of grant. In 2024, PHINIA granted restricted stock in the amount of approximately 360 thousand shares and 20 thousand shares to employees and non-employee directors, respectively. The value of the awards is recognized as compensation expense ratably over the restriction periods, generally two or three years for employees and one year for non-employee directors. As of December 31, 2024, there was $ 16 million of unrecognized compensation expense related to restricted stock that will be recognized over a weighted average period of approximately 1.7 years. | text | 360 | sharesItemType | text: <entity> 360 </entity> <entity type> sharesItemType </entity type> <context> The value of restricted stock is determined by the market value of the Company’s common stock at the date of grant. In 2024, PHINIA granted restricted stock in the amount of approximately 360 thousand shares and 20 thousand shares to employees and non-employee directors, respectively. The value of the awards is recognized as compensation expense ratably over the restriction periods, generally two or three years for employees and one year for non-employee directors. As of December 31, 2024, there was $ 16 million of unrecognized compensation expense related to restricted stock that will be recognized over a weighted average period of approximately 1.7 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The value of restricted stock is determined by the market value of the Company’s common stock at the date of grant. In 2024, PHINIA granted restricted stock in the amount of approximately 360 thousand shares and 20 thousand shares to employees and non-employee directors, respectively. The value of the awards is recognized as compensation expense ratably over the restriction periods, generally two or three years for employees and one year for non-employee directors. As of December 31, 2024, there was $ 16 million of unrecognized compensation expense related to restricted stock that will be recognized over a weighted average period of approximately 1.7 years. | text | 20 | sharesItemType | text: <entity> 20 </entity> <entity type> sharesItemType </entity type> <context> The value of restricted stock is determined by the market value of the Company’s common stock at the date of grant. In 2024, PHINIA granted restricted stock in the amount of approximately 360 thousand shares and 20 thousand shares to employees and non-employee directors, respectively. The value of the awards is recognized as compensation expense ratably over the restriction periods, generally two or three years for employees and one year for non-employee directors. As of December 31, 2024, there was $ 16 million of unrecognized compensation expense related to restricted stock that will be recognized over a weighted average period of approximately 1.7 years. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
The value of restricted stock is determined by the market value of the Company’s common stock at the date of grant. In 2024, PHINIA granted restricted stock in the amount of approximately 360 thousand shares and 20 thousand shares to employees and non-employee directors, respectively. The value of the awards is recognized as compensation expense ratably over the restriction periods, generally two or three years for employees and one year for non-employee directors. As of December 31, 2024, there was $ 16 million of unrecognized compensation expense related to restricted stock that will be recognized over a weighted average period of approximately 1.7 years. | text | 16 | monetaryItemType | text: <entity> 16 </entity> <entity type> monetaryItemType </entity type> <context> The value of restricted stock is determined by the market value of the Company’s common stock at the date of grant. In 2024, PHINIA granted restricted stock in the amount of approximately 360 thousand shares and 20 thousand shares to employees and non-employee directors, respectively. The value of the awards is recognized as compensation expense ratably over the restriction periods, generally two or three years for employees and one year for non-employee directors. As of December 31, 2024, there was $ 16 million of unrecognized compensation expense related to restricted stock that will be recognized over a weighted average period of approximately 1.7 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions |
: This performance metric is based on the Company’s market performance in terms of total stockholder return relative to a peer group of automotive and industrial companies. Based on the Company’s relative ranking within the performance peer group, it is possible for none of the awards to vest or for a range of up to 200 % of the target shares to vest. | text | 200 | percentItemType | text: <entity> 200 </entity> <entity type> percentItemType </entity type> <context> : This performance metric is based on the Company’s market performance in terms of total stockholder return relative to a peer group of automotive and industrial companies. Based on the Company’s relative ranking within the performance peer group, it is possible for none of the awards to vest or for a range of up to 200 % of the target shares to vest. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum |
As of December 31, 2024, there was $ 6 million of unrecognized compensation expense related to total stockholder return units that will be recognized over a weighted average period of approximately 2 years. | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there was $ 6 million of unrecognized compensation expense related to total stockholder return units that will be recognized over a weighted average period of approximately 2 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions |
In the years ended December 31, 2024, 2023 and 2022, the Company recorded operating lease expense of $ 20 million, $ 15 million and $ 18 million, respectively. | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2024, 2023 and 2022, the Company recorded operating lease expense of $ 20 million, $ 15 million and $ 18 million, respectively. </context> | us-gaap:OperatingLeaseCost |
In the years ended December 31, 2024, 2023 and 2022, the Company recorded operating lease expense of $ 20 million, $ 15 million and $ 18 million, respectively. | text | 15 | monetaryItemType | text: <entity> 15 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2024, 2023 and 2022, the Company recorded operating lease expense of $ 20 million, $ 15 million and $ 18 million, respectively. </context> | us-gaap:OperatingLeaseCost |
In the years ended December 31, 2024, 2023 and 2022, the Company recorded operating lease expense of $ 20 million, $ 15 million and $ 18 million, respectively. | text | 18 | monetaryItemType | text: <entity> 18 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2024, 2023 and 2022, the Company recorded operating lease expense of $ 20 million, $ 15 million and $ 18 million, respectively. </context> | us-gaap:OperatingLeaseCost |
In the years ended December 31, 2024, 2023 and 2022, the operating cash flows for operating leases were $ 20 million, $ 20 million and $ 21 million, respectively. | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2024, 2023 and 2022, the operating cash flows for operating leases were $ 20 million, $ 20 million and $ 21 million, respectively. </context> | us-gaap:OperatingLeasePayments |
In the years ended December 31, 2024, 2023 and 2022, the operating cash flows for operating leases were $ 20 million, $ 20 million and $ 21 million, respectively. | text | 21 | monetaryItemType | text: <entity> 21 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2024, 2023 and 2022, the operating cash flows for operating leases were $ 20 million, $ 20 million and $ 21 million, respectively. </context> | us-gaap:OperatingLeasePayments |
In the years ended December 31, 2024, 2023 and 2022, the Company recorded short-term lease costs of $ 5 million, $ 1 million and $ 4 million, respectively. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2024, 2023 and 2022, the Company recorded short-term lease costs of $ 5 million, $ 1 million and $ 4 million, respectively. </context> | us-gaap:ShortTermLeaseCost |
In the years ended December 31, 2024, 2023 and 2022, the Company recorded short-term lease costs of $ 5 million, $ 1 million and $ 4 million, respectively. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2024, 2023 and 2022, the Company recorded short-term lease costs of $ 5 million, $ 1 million and $ 4 million, respectively. </context> | us-gaap:ShortTermLeaseCost |
In the years ended December 31, 2024, 2023 and 2022, the Company recorded short-term lease costs of $ 5 million, $ 1 million and $ 4 million, respectively. | text | 4 | monetaryItemType | text: <entity> 4 </entity> <entity type> monetaryItemType </entity type> <context> In the years ended December 31, 2024, 2023 and 2022, the Company recorded short-term lease costs of $ 5 million, $ 1 million and $ 4 million, respectively. </context> | us-gaap:ShortTermLeaseCost |
For periods prior to July 3, 2023, the denominator for basic and diluted earnings per share was calculated using the 47.0 million PHINIA ordinary shares outstanding immediately following the Spin-Off. The same number of shares was used to calculate basic and diluted earnings per share in those periods since no PHINIA equity awards were outstanding prior to the Spin-Off. | text | 47.0 | sharesItemType | text: <entity> 47.0 </entity> <entity type> sharesItemType </entity type> <context> For periods prior to July 3, 2023, the denominator for basic and diluted earnings per share was calculated using the 47.0 million PHINIA ordinary shares outstanding immediately following the Spin-Off. The same number of shares was used to calculate basic and diluted earnings per share in those periods since no PHINIA equity awards were outstanding prior to the Spin-Off. </context> | us-gaap:WeightedAverageNumberOfSharesOutstandingBasic |
Net corporate allocation expenses, primarily related to separation and transaction costs, in the years ended December 31, 2023 and 2022 totaled $ 89 million and $ 118 million, respectively. These expenses were primarily included in Selling, general and administrative expenses and Other operating expense (income), net in the Consolidated Statements of Operations. | text | 89 | monetaryItemType | text: <entity> 89 </entity> <entity type> monetaryItemType </entity type> <context> Net corporate allocation expenses, primarily related to separation and transaction costs, in the years ended December 31, 2023 and 2022 totaled $ 89 million and $ 118 million, respectively. These expenses were primarily included in Selling, general and administrative expenses and Other operating expense (income), net in the Consolidated Statements of Operations. </context> | us-gaap:SellingGeneralAndAdministrativeExpense |
Net corporate allocation expenses, primarily related to separation and transaction costs, in the years ended December 31, 2023 and 2022 totaled $ 89 million and $ 118 million, respectively. These expenses were primarily included in Selling, general and administrative expenses and Other operating expense (income), net in the Consolidated Statements of Operations. | text | 118 | monetaryItemType | text: <entity> 118 </entity> <entity type> monetaryItemType </entity type> <context> Net corporate allocation expenses, primarily related to separation and transaction costs, in the years ended December 31, 2023 and 2022 totaled $ 89 million and $ 118 million, respectively. These expenses were primarily included in Selling, general and administrative expenses and Other operating expense (income), net in the Consolidated Statements of Operations. </context> | us-gaap:SellingGeneralAndAdministrativeExpense |
The Company’s business is comprised of two reportable segments, which are further described below. These segments are strategic business groups, which are managed separately as each represents a specific grouping of related automotive components and systems. | text | two | integerItemType | text: <entity> two </entity> <entity type> integerItemType </entity type> <context> The Company’s business is comprised of two reportable segments, which are further described below. These segments are strategic business groups, which are managed separately as each represents a specific grouping of related automotive components and systems. </context> | us-gaap:NumberOfReportableSegments |
During the years ended December 31, 2024, 2023 and 2022, approximately 63 %, 63 % and 65 % of the Company’s consolidated net sales were outside the U.S., respectively, attributing sales to the location of billing rather than the location of the customer. Outside the United States, no countries other than those presented below exceeded 5% of consolidated net sales during the years ended December 31, 2024, 2023, and 2022. | text | 63 | percentItemType | text: <entity> 63 </entity> <entity type> percentItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, approximately 63 %, 63 % and 65 % of the Company’s consolidated net sales were outside the U.S., respectively, attributing sales to the location of billing rather than the location of the customer. Outside the United States, no countries other than those presented below exceeded 5% of consolidated net sales during the years ended December 31, 2024, 2023, and 2022. </context> | us-gaap:ConcentrationRiskPercentage1 |
During the years ended December 31, 2024, 2023 and 2022, approximately 63 %, 63 % and 65 % of the Company’s consolidated net sales were outside the U.S., respectively, attributing sales to the location of billing rather than the location of the customer. Outside the United States, no countries other than those presented below exceeded 5% of consolidated net sales during the years ended December 31, 2024, 2023, and 2022. | text | 65 | percentItemType | text: <entity> 65 </entity> <entity type> percentItemType </entity type> <context> During the years ended December 31, 2024, 2023 and 2022, approximately 63 %, 63 % and 65 % of the Company’s consolidated net sales were outside the U.S., respectively, attributing sales to the location of billing rather than the location of the customer. Outside the United States, no countries other than those presented below exceeded 5% of consolidated net sales during the years ended December 31, 2024, 2023, and 2022. </context> | us-gaap:ConcentrationRiskPercentage1 |
Consolidated net sales to General Motors Company (including its subsidiaries) were approximately 17 %, 16 %, and 12 % for the years ended December 31, 2024, 2023, and 2022, respectively. Such sales consisted of a variety of products to a variety of customer locations and regions. No other single customer accounted for more than 10% of consolidated net sales in any of the years presented. | text | 17 | percentItemType | text: <entity> 17 </entity> <entity type> percentItemType </entity type> <context> Consolidated net sales to General Motors Company (including its subsidiaries) were approximately 17 %, 16 %, and 12 % for the years ended December 31, 2024, 2023, and 2022, respectively. Such sales consisted of a variety of products to a variety of customer locations and regions. No other single customer accounted for more than 10% of consolidated net sales in any of the years presented. </context> | us-gaap:ConcentrationRiskPercentage1 |
Consolidated net sales to General Motors Company (including its subsidiaries) were approximately 17 %, 16 %, and 12 % for the years ended December 31, 2024, 2023, and 2022, respectively. Such sales consisted of a variety of products to a variety of customer locations and regions. No other single customer accounted for more than 10% of consolidated net sales in any of the years presented. | text | 16 | percentItemType | text: <entity> 16 </entity> <entity type> percentItemType </entity type> <context> Consolidated net sales to General Motors Company (including its subsidiaries) were approximately 17 %, 16 %, and 12 % for the years ended December 31, 2024, 2023, and 2022, respectively. Such sales consisted of a variety of products to a variety of customer locations and regions. No other single customer accounted for more than 10% of consolidated net sales in any of the years presented. </context> | us-gaap:ConcentrationRiskPercentage1 |
Consolidated net sales to General Motors Company (including its subsidiaries) were approximately 17 %, 16 %, and 12 % for the years ended December 31, 2024, 2023, and 2022, respectively. Such sales consisted of a variety of products to a variety of customer locations and regions. No other single customer accounted for more than 10% of consolidated net sales in any of the years presented. | text | 12 | percentItemType | text: <entity> 12 </entity> <entity type> percentItemType </entity type> <context> Consolidated net sales to General Motors Company (including its subsidiaries) were approximately 17 %, 16 %, and 12 % for the years ended December 31, 2024, 2023, and 2022, respectively. Such sales consisted of a variety of products to a variety of customer locations and regions. No other single customer accounted for more than 10% of consolidated net sales in any of the years presented. </context> | us-gaap:ConcentrationRiskPercentage1 |
The accompanying financial statements are presented on a going concern basis. The Company has had limited operations during the period from January 23, 2012 (date of inception) to October 31, 2024 and generated an accumulated deficit of $ 216,439 . This condition raises substantial doubt about the Company’s ability to continue as a going concern. The Company is currently in the exploration stage with no operations and has minimal expenses, however, management believes that the Company’s current cash is insufficient to cover the expenses they will incur during the next twelve months in a limited operations scenario or until it raises additional funding. The Company has depended upon loans from its president and shareholders for operating capital. As of October 31, 2024, the Company had a working capital deficit of $ 156,439 and $ 0 cash, compared to a working capital deficit of $ 134,026 and cash of $ 0 as of October 31, 2023. | text | 216439 | monetaryItemType | text: <entity> 216439 </entity> <entity type> monetaryItemType </entity type> <context> The accompanying financial statements are presented on a going concern basis. The Company has had limited operations during the period from January 23, 2012 (date of inception) to October 31, 2024 and generated an accumulated deficit of $ 216,439 . This condition raises substantial doubt about the Company’s ability to continue as a going concern. The Company is currently in the exploration stage with no operations and has minimal expenses, however, management believes that the Company’s current cash is insufficient to cover the expenses they will incur during the next twelve months in a limited operations scenario or until it raises additional funding. The Company has depended upon loans from its president and shareholders for operating capital. As of October 31, 2024, the Company had a working capital deficit of $ 156,439 and $ 0 cash, compared to a working capital deficit of $ 134,026 and cash of $ 0 as of October 31, 2023. </context> | us-gaap:RetainedEarningsAccumulatedDeficit |
The accompanying financial statements are presented on a going concern basis. The Company has had limited operations during the period from January 23, 2012 (date of inception) to October 31, 2024 and generated an accumulated deficit of $ 216,439 . This condition raises substantial doubt about the Company’s ability to continue as a going concern. The Company is currently in the exploration stage with no operations and has minimal expenses, however, management believes that the Company’s current cash is insufficient to cover the expenses they will incur during the next twelve months in a limited operations scenario or until it raises additional funding. The Company has depended upon loans from its president and shareholders for operating capital. As of October 31, 2024, the Company had a working capital deficit of $ 156,439 and $ 0 cash, compared to a working capital deficit of $ 134,026 and cash of $ 0 as of October 31, 2023. | text | 0 | monetaryItemType | text: <entity> 0 </entity> <entity type> monetaryItemType </entity type> <context> The accompanying financial statements are presented on a going concern basis. The Company has had limited operations during the period from January 23, 2012 (date of inception) to October 31, 2024 and generated an accumulated deficit of $ 216,439 . This condition raises substantial doubt about the Company’s ability to continue as a going concern. The Company is currently in the exploration stage with no operations and has minimal expenses, however, management believes that the Company’s current cash is insufficient to cover the expenses they will incur during the next twelve months in a limited operations scenario or until it raises additional funding. The Company has depended upon loans from its president and shareholders for operating capital. As of October 31, 2024, the Company had a working capital deficit of $ 156,439 and $ 0 cash, compared to a working capital deficit of $ 134,026 and cash of $ 0 as of October 31, 2023. </context> | us-gaap:CashEquivalentsAtCarryingValue |
Common stock, $ 0.001 par value: 450,000,000 shares authorized; 120,000,000 shares issued and outstanding. | text | 0.001 | perShareItemType | text: <entity> 0.001 </entity> <entity type> perShareItemType </entity type> <context> Common stock, $ 0.001 par value: 450,000,000 shares authorized; 120,000,000 shares issued and outstanding. </context> | us-gaap:CommonStockParOrStatedValuePerShare |
Common stock, $ 0.001 par value: 450,000,000 shares authorized; 120,000,000 shares issued and outstanding. | text | 450000000 | sharesItemType | text: <entity> 450000000 </entity> <entity type> sharesItemType </entity type> <context> Common stock, $ 0.001 par value: 450,000,000 shares authorized; 120,000,000 shares issued and outstanding. </context> | us-gaap:CommonStockSharesAuthorized |
Common stock, $ 0.001 par value: 450,000,000 shares authorized; 120,000,000 shares issued and outstanding. | text | 120000000 | sharesItemType | text: <entity> 120000000 </entity> <entity type> sharesItemType </entity type> <context> Common stock, $ 0.001 par value: 450,000,000 shares authorized; 120,000,000 shares issued and outstanding. </context> | us-gaap:CommonStockSharesIssued |
With operations in over 15 countries, we are a global provider of drilling and drilling-related services for land-based and offshore oil and natural gas wells, with a fleet of rigs and drilling-related equipment which, as of December 31, 2024 included: | text | 15 | integerItemType | text: <entity> 15 </entity> <entity type> integerItemType </entity type> <context> With operations in over 15 countries, we are a global provider of drilling and drilling-related services for land-based and offshore oil and natural gas wells, with a fleet of rigs and drilling-related equipment which, as of December 31, 2024 included: </context> | us-gaap:NumberOfCountriesInWhichEntityOperates |
The short- and long-term implications of the military hostilities between Russia and Ukraine, which began in early 2022, are difficult to predict at this time. We continue to actively monitor this dynamic situation. As of December 31, 2024 and 2023, 0.7 % and 0.9 % of our property, plant and equipment, net was located in Russia, respectively. For the years ending December 31, 2024 and 2023, 0.9 % and 1.1 % of our operating revenues was from operations in Russia, respectively. We currently have no assets or operations in Ukraine. | text | 0.7 | percentItemType | text: <entity> 0.7 </entity> <entity type> percentItemType </entity type> <context> The short- and long-term implications of the military hostilities between Russia and Ukraine, which began in early 2022, are difficult to predict at this time. We continue to actively monitor this dynamic situation. As of December 31, 2024 and 2023, 0.7 % and 0.9 % of our property, plant and equipment, net was located in Russia, respectively. For the years ending December 31, 2024 and 2023, 0.9 % and 1.1 % of our operating revenues was from operations in Russia, respectively. We currently have no assets or operations in Ukraine. </context> | us-gaap:ConcentrationRiskPercentage1 |
The short- and long-term implications of the military hostilities between Russia and Ukraine, which began in early 2022, are difficult to predict at this time. We continue to actively monitor this dynamic situation. As of December 31, 2024 and 2023, 0.7 % and 0.9 % of our property, plant and equipment, net was located in Russia, respectively. For the years ending December 31, 2024 and 2023, 0.9 % and 1.1 % of our operating revenues was from operations in Russia, respectively. We currently have no assets or operations in Ukraine. | text | 0.9 | percentItemType | text: <entity> 0.9 </entity> <entity type> percentItemType </entity type> <context> The short- and long-term implications of the military hostilities between Russia and Ukraine, which began in early 2022, are difficult to predict at this time. We continue to actively monitor this dynamic situation. As of December 31, 2024 and 2023, 0.7 % and 0.9 % of our property, plant and equipment, net was located in Russia, respectively. For the years ending December 31, 2024 and 2023, 0.9 % and 1.1 % of our operating revenues was from operations in Russia, respectively. We currently have no assets or operations in Ukraine. </context> | us-gaap:ConcentrationRiskPercentage1 |
The short- and long-term implications of the military hostilities between Russia and Ukraine, which began in early 2022, are difficult to predict at this time. We continue to actively monitor this dynamic situation. As of December 31, 2024 and 2023, 0.7 % and 0.9 % of our property, plant and equipment, net was located in Russia, respectively. For the years ending December 31, 2024 and 2023, 0.9 % and 1.1 % of our operating revenues was from operations in Russia, respectively. We currently have no assets or operations in Ukraine. | text | 1.1 | percentItemType | text: <entity> 1.1 </entity> <entity type> percentItemType </entity type> <context> The short- and long-term implications of the military hostilities between Russia and Ukraine, which began in early 2022, are difficult to predict at this time. We continue to actively monitor this dynamic situation. As of December 31, 2024 and 2023, 0.7 % and 0.9 % of our property, plant and equipment, net was located in Russia, respectively. For the years ending December 31, 2024 and 2023, 0.9 % and 1.1 % of our operating revenues was from operations in Russia, respectively. We currently have no assets or operations in Ukraine. </context> | us-gaap:ConcentrationRiskPercentage1 |
The short- and long-term implications of the military hostilities between Russia and Ukraine, which began in early 2022, are difficult to predict at this time. We continue to actively monitor this dynamic situation. As of December 31, 2024 and 2023, 0.7 % and 0.9 % of our property, plant and equipment, net was located in Russia, respectively. For the years ending December 31, 2024 and 2023, 0.9 % and 1.1 % of our operating revenues was from operations in Russia, respectively. We currently have no assets or operations in Ukraine. | text | no | percentItemType | text: <entity> no </entity> <entity type> percentItemType </entity type> <context> The short- and long-term implications of the military hostilities between Russia and Ukraine, which began in early 2022, are difficult to predict at this time. We continue to actively monitor this dynamic situation. As of December 31, 2024 and 2023, 0.7 % and 0.9 % of our property, plant and equipment, net was located in Russia, respectively. For the years ending December 31, 2024 and 2023, 0.9 % and 1.1 % of our operating revenues was from operations in Russia, respectively. We currently have no assets or operations in Ukraine. </context> | us-gaap:ConcentrationRiskPercentage1 |
Inventory is stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out or weighted-average costs methods and includes the cost of materials, labor and manufacturing overhead. Inventory, which is presented net of reserves of $ 24.3 million and $ 23.9 million as of December 31, 2024 and 2023, respectively, included the following: | text | 24.3 | monetaryItemType | text: <entity> 24.3 </entity> <entity type> monetaryItemType </entity type> <context> Inventory is stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out or weighted-average costs methods and includes the cost of materials, labor and manufacturing overhead. Inventory, which is presented net of reserves of $ 24.3 million and $ 23.9 million as of December 31, 2024 and 2023, respectively, included the following: </context> | us-gaap:InventoryAdjustments |
Inventory is stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out or weighted-average costs methods and includes the cost of materials, labor and manufacturing overhead. Inventory, which is presented net of reserves of $ 24.3 million and $ 23.9 million as of December 31, 2024 and 2023, respectively, included the following: | text | 23.9 | monetaryItemType | text: <entity> 23.9 </entity> <entity type> monetaryItemType </entity type> <context> Inventory is stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out or weighted-average costs methods and includes the cost of materials, labor and manufacturing overhead. Inventory, which is presented net of reserves of $ 24.3 million and $ 23.9 million as of December 31, 2024 and 2023, respectively, included the following: </context> | us-gaap:InventoryAdjustments |
The Company entered into an accounts receivable sales agreement (the “A/R Sales Agreement”) and an accounts receivable purchase agreement (the “A/R Purchase Agreement,” and, together with the A/R Sales Agreement, the “A/R Agreements”). As part of the A/R Agreements, the Company continuously sells designated eligible pools of receivables as they are originated by it and certain of its U.S. subsidiaries to a separate, bankruptcy-remote, special purpose entity (“SPE”) pursuant to the A/R Sales Agreement. Pursuant to the A/R Purchase Agreement, the SPE in turn sells, transfers, conveys and assigns to unaffiliated third-party financial institutions (the “Purchasers”) all the rights, title and interest in and to its pool of eligible receivables (the “Eligible Receivables”). The sale of the Eligible Receivables qualifies for sale accounting treatment in accordance with ASC 860 – Transfers and Servicing. During the period of this program, cash receipts from the Purchasers at the time of the sale are classified as operating activities in our consolidated statement of cash flows and the associated receivables are derecognized from the Company’s consolidated balance sheet at the time of the sale. The remaining receivables held by the SPE were pledged to secure the collectability of the sold Eligible Receivables. Subsequent collections on the pledged receivables, which have not been sold, will be classified as operating cash flows in our consolidated statement of cash flows at the time of collection. The amount of receivables pledged as collateral as of December 31, 2024 and 2023 is approximately $ 44.6 million and $ 67.0 million, respectively. | text | 44.6 | monetaryItemType | text: <entity> 44.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company entered into an accounts receivable sales agreement (the “A/R Sales Agreement”) and an accounts receivable purchase agreement (the “A/R Purchase Agreement,” and, together with the A/R Sales Agreement, the “A/R Agreements”). As part of the A/R Agreements, the Company continuously sells designated eligible pools of receivables as they are originated by it and certain of its U.S. subsidiaries to a separate, bankruptcy-remote, special purpose entity (“SPE”) pursuant to the A/R Sales Agreement. Pursuant to the A/R Purchase Agreement, the SPE in turn sells, transfers, conveys and assigns to unaffiliated third-party financial institutions (the “Purchasers”) all the rights, title and interest in and to its pool of eligible receivables (the “Eligible Receivables”). The sale of the Eligible Receivables qualifies for sale accounting treatment in accordance with ASC 860 – Transfers and Servicing. During the period of this program, cash receipts from the Purchasers at the time of the sale are classified as operating activities in our consolidated statement of cash flows and the associated receivables are derecognized from the Company’s consolidated balance sheet at the time of the sale. The remaining receivables held by the SPE were pledged to secure the collectability of the sold Eligible Receivables. Subsequent collections on the pledged receivables, which have not been sold, will be classified as operating cash flows in our consolidated statement of cash flows at the time of collection. The amount of receivables pledged as collateral as of December 31, 2024 and 2023 is approximately $ 44.6 million and $ 67.0 million, respectively. </context> | us-gaap:AccountsReceivableGross |
The Company entered into an accounts receivable sales agreement (the “A/R Sales Agreement”) and an accounts receivable purchase agreement (the “A/R Purchase Agreement,” and, together with the A/R Sales Agreement, the “A/R Agreements”). As part of the A/R Agreements, the Company continuously sells designated eligible pools of receivables as they are originated by it and certain of its U.S. subsidiaries to a separate, bankruptcy-remote, special purpose entity (“SPE”) pursuant to the A/R Sales Agreement. Pursuant to the A/R Purchase Agreement, the SPE in turn sells, transfers, conveys and assigns to unaffiliated third-party financial institutions (the “Purchasers”) all the rights, title and interest in and to its pool of eligible receivables (the “Eligible Receivables”). The sale of the Eligible Receivables qualifies for sale accounting treatment in accordance with ASC 860 – Transfers and Servicing. During the period of this program, cash receipts from the Purchasers at the time of the sale are classified as operating activities in our consolidated statement of cash flows and the associated receivables are derecognized from the Company’s consolidated balance sheet at the time of the sale. The remaining receivables held by the SPE were pledged to secure the collectability of the sold Eligible Receivables. Subsequent collections on the pledged receivables, which have not been sold, will be classified as operating cash flows in our consolidated statement of cash flows at the time of collection. The amount of receivables pledged as collateral as of December 31, 2024 and 2023 is approximately $ 44.6 million and $ 67.0 million, respectively. | text | 67.0 | monetaryItemType | text: <entity> 67.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company entered into an accounts receivable sales agreement (the “A/R Sales Agreement”) and an accounts receivable purchase agreement (the “A/R Purchase Agreement,” and, together with the A/R Sales Agreement, the “A/R Agreements”). As part of the A/R Agreements, the Company continuously sells designated eligible pools of receivables as they are originated by it and certain of its U.S. subsidiaries to a separate, bankruptcy-remote, special purpose entity (“SPE”) pursuant to the A/R Sales Agreement. Pursuant to the A/R Purchase Agreement, the SPE in turn sells, transfers, conveys and assigns to unaffiliated third-party financial institutions (the “Purchasers”) all the rights, title and interest in and to its pool of eligible receivables (the “Eligible Receivables”). The sale of the Eligible Receivables qualifies for sale accounting treatment in accordance with ASC 860 – Transfers and Servicing. During the period of this program, cash receipts from the Purchasers at the time of the sale are classified as operating activities in our consolidated statement of cash flows and the associated receivables are derecognized from the Company’s consolidated balance sheet at the time of the sale. The remaining receivables held by the SPE were pledged to secure the collectability of the sold Eligible Receivables. Subsequent collections on the pledged receivables, which have not been sold, will be classified as operating cash flows in our consolidated statement of cash flows at the time of collection. The amount of receivables pledged as collateral as of December 31, 2024 and 2023 is approximately $ 44.6 million and $ 67.0 million, respectively. </context> | us-gaap:AccountsReceivableGross |
The amount available for sale to the Purchasers under the A/R Purchase Agreement fluctuates over time based on the total amount of Eligible Receivables generated during the normal course of business after excluding excess concentrations and certain other ineligible receivables. As of December 31, 2024 and 2023, approximately $ 130.0 million and $ 145.0 million had been sold to and as yet uncollected by the Purchasers, respectively. | text | 130.0 | monetaryItemType | text: <entity> 130.0 </entity> <entity type> monetaryItemType </entity type> <context> The amount available for sale to the Purchasers under the A/R Purchase Agreement fluctuates over time based on the total amount of Eligible Receivables generated during the normal course of business after excluding excess concentrations and certain other ineligible receivables. As of December 31, 2024 and 2023, approximately $ 130.0 million and $ 145.0 million had been sold to and as yet uncollected by the Purchasers, respectively. </context> | us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized |
The amount available for sale to the Purchasers under the A/R Purchase Agreement fluctuates over time based on the total amount of Eligible Receivables generated during the normal course of business after excluding excess concentrations and certain other ineligible receivables. As of December 31, 2024 and 2023, approximately $ 130.0 million and $ 145.0 million had been sold to and as yet uncollected by the Purchasers, respectively. | text | 145.0 | monetaryItemType | text: <entity> 145.0 </entity> <entity type> monetaryItemType </entity type> <context> The amount available for sale to the Purchasers under the A/R Purchase Agreement fluctuates over time based on the total amount of Eligible Receivables generated during the normal course of business after excluding excess concentrations and certain other ineligible receivables. As of December 31, 2024 and 2023, approximately $ 130.0 million and $ 145.0 million had been sold to and as yet uncollected by the Purchasers, respectively. </context> | us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized |
On October 14, 2024, we and certain subsidiaries of ours entered into a merger agreement (the “Merger Agreement”) to acquire Parker Drilling Company (“Parker”), pursuant to which, upon the terms and subject to the conditions set forth therein, we will acquire Parker for 4.8 million of our common shares, subject to a collar. The precise number of shares to be issued to Parker stockholders will be determined based upon the volume weighted average price of Nabors common shares on the NYSE for the 15 trading days ending the fifth day before the closing of the merger (“Closing Price”) and, if that Closing Price is below $ 42.70 , Parker stockholders will also receive a cash component for their shares of Parker stock. If the volume weighted average price is above $ 99.62 , the merger consideration will consist of the number of shares equal to $ 478,176,000 divided by the Closing Price. | text | 42.70 | perShareItemType | text: <entity> 42.70 </entity> <entity type> perShareItemType </entity type> <context> On October 14, 2024, we and certain subsidiaries of ours entered into a merger agreement (the “Merger Agreement”) to acquire Parker Drilling Company (“Parker”), pursuant to which, upon the terms and subject to the conditions set forth therein, we will acquire Parker for 4.8 million of our common shares, subject to a collar. The precise number of shares to be issued to Parker stockholders will be determined based upon the volume weighted average price of Nabors common shares on the NYSE for the 15 trading days ending the fifth day before the closing of the merger (“Closing Price”) and, if that Closing Price is below $ 42.70 , Parker stockholders will also receive a cash component for their shares of Parker stock. If the volume weighted average price is above $ 99.62 , the merger consideration will consist of the number of shares equal to $ 478,176,000 divided by the Closing Price. </context> | us-gaap:BusinessAcquisitionSharePrice |
On October 14, 2024, we and certain subsidiaries of ours entered into a merger agreement (the “Merger Agreement”) to acquire Parker Drilling Company (“Parker”), pursuant to which, upon the terms and subject to the conditions set forth therein, we will acquire Parker for 4.8 million of our common shares, subject to a collar. The precise number of shares to be issued to Parker stockholders will be determined based upon the volume weighted average price of Nabors common shares on the NYSE for the 15 trading days ending the fifth day before the closing of the merger (“Closing Price”) and, if that Closing Price is below $ 42.70 , Parker stockholders will also receive a cash component for their shares of Parker stock. If the volume weighted average price is above $ 99.62 , the merger consideration will consist of the number of shares equal to $ 478,176,000 divided by the Closing Price. | text | 99.62 | perShareItemType | text: <entity> 99.62 </entity> <entity type> perShareItemType </entity type> <context> On October 14, 2024, we and certain subsidiaries of ours entered into a merger agreement (the “Merger Agreement”) to acquire Parker Drilling Company (“Parker”), pursuant to which, upon the terms and subject to the conditions set forth therein, we will acquire Parker for 4.8 million of our common shares, subject to a collar. The precise number of shares to be issued to Parker stockholders will be determined based upon the volume weighted average price of Nabors common shares on the NYSE for the 15 trading days ending the fifth day before the closing of the merger (“Closing Price”) and, if that Closing Price is below $ 42.70 , Parker stockholders will also receive a cash component for their shares of Parker stock. If the volume weighted average price is above $ 99.62 , the merger consideration will consist of the number of shares equal to $ 478,176,000 divided by the Closing Price. </context> | us-gaap:BusinessAcquisitionSharePrice |
On October 14, 2024, we and certain subsidiaries of ours entered into a merger agreement (the “Merger Agreement”) to acquire Parker Drilling Company (“Parker”), pursuant to which, upon the terms and subject to the conditions set forth therein, we will acquire Parker for 4.8 million of our common shares, subject to a collar. The precise number of shares to be issued to Parker stockholders will be determined based upon the volume weighted average price of Nabors common shares on the NYSE for the 15 trading days ending the fifth day before the closing of the merger (“Closing Price”) and, if that Closing Price is below $ 42.70 , Parker stockholders will also receive a cash component for their shares of Parker stock. If the volume weighted average price is above $ 99.62 , the merger consideration will consist of the number of shares equal to $ 478,176,000 divided by the Closing Price. | text | 478176000 | monetaryItemType | text: <entity> 478176000 </entity> <entity type> monetaryItemType </entity type> <context> On October 14, 2024, we and certain subsidiaries of ours entered into a merger agreement (the “Merger Agreement”) to acquire Parker Drilling Company (“Parker”), pursuant to which, upon the terms and subject to the conditions set forth therein, we will acquire Parker for 4.8 million of our common shares, subject to a collar. The precise number of shares to be issued to Parker stockholders will be determined based upon the volume weighted average price of Nabors common shares on the NYSE for the 15 trading days ending the fifth day before the closing of the merger (“Closing Price”) and, if that Closing Price is below $ 42.70 , Parker stockholders will also receive a cash component for their shares of Parker stock. If the volume weighted average price is above $ 99.62 , the merger consideration will consist of the number of shares equal to $ 478,176,000 divided by the Closing Price. </context> | us-gaap:BusinessCombinationPriceOfAcquisitionExpected |
Total share-based compensation expense, which includes stock options and restricted shares, was $ 16.5 million, $ 15.8 million and $ 15.8 million for 2024, 2023 and 2022, respectively. Compensation expense related to awards of restricted shares totaled $ 16.5 million, $ 15.8 million and $ 15.8 million 2024, 2023 and 2022, respectively, which is included in general and administrative and research and engineering expenses in our consolidated statements of income (loss). Share-based compensation expense has been allocated to our various reportable segments. See Note 17—Segment Information. | text | 16.5 | monetaryItemType | text: <entity> 16.5 </entity> <entity type> monetaryItemType </entity type> <context> Total share-based compensation expense, which includes stock options and restricted shares, was $ 16.5 million, $ 15.8 million and $ 15.8 million for 2024, 2023 and 2022, respectively. Compensation expense related to awards of restricted shares totaled $ 16.5 million, $ 15.8 million and $ 15.8 million 2024, 2023 and 2022, respectively, which is included in general and administrative and research and engineering expenses in our consolidated statements of income (loss). Share-based compensation expense has been allocated to our various reportable segments. See Note 17—Segment Information. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
Total share-based compensation expense, which includes stock options and restricted shares, was $ 16.5 million, $ 15.8 million and $ 15.8 million for 2024, 2023 and 2022, respectively. Compensation expense related to awards of restricted shares totaled $ 16.5 million, $ 15.8 million and $ 15.8 million 2024, 2023 and 2022, respectively, which is included in general and administrative and research and engineering expenses in our consolidated statements of income (loss). Share-based compensation expense has been allocated to our various reportable segments. See Note 17—Segment Information. | text | 15.8 | monetaryItemType | text: <entity> 15.8 </entity> <entity type> monetaryItemType </entity type> <context> Total share-based compensation expense, which includes stock options and restricted shares, was $ 16.5 million, $ 15.8 million and $ 15.8 million for 2024, 2023 and 2022, respectively. Compensation expense related to awards of restricted shares totaled $ 16.5 million, $ 15.8 million and $ 15.8 million 2024, 2023 and 2022, respectively, which is included in general and administrative and research and engineering expenses in our consolidated statements of income (loss). Share-based compensation expense has been allocated to our various reportable segments. See Note 17—Segment Information. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
There are approximately 0.4 million common shares available for issuance in the form of either restricted shares or stock options, under these plans as of December 31, 2024. | text | 0.4 | sharesItemType | text: <entity> 0.4 </entity> <entity type> sharesItemType </entity type> <context> There are approximately 0.4 million common shares available for issuance in the form of either restricted shares or stock options, under these plans as of December 31, 2024. </context> | us-gaap:CommonStockCapitalSharesReservedForFutureIssuance |
During 2022, we awarded options vesting immediately to purchase 1,056 of our common stock to certain of our directors. No stock options were awarded during 2023 or 2024. There were no unvested options outstanding at the end of 2022, 2023 or 2024. | text | 1056 | sharesItemType | text: <entity> 1056 </entity> <entity type> sharesItemType </entity type> <context> During 2022, we awarded options vesting immediately to purchase 1,056 of our common stock to certain of our directors. No stock options were awarded during 2023 or 2024. There were no unvested options outstanding at the end of 2022, 2023 or 2024. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross |
There were no options exercised during 2024, 2023 or 2022. The total fair value of options that vested during the year ended December 31, 2022 was $ 0.2 million. | text | 0.2 | monetaryItemType | text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> There were no options exercised during 2024, 2023 or 2022. The total fair value of options that vested during the year ended December 31, 2022 was $ 0.2 million. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 |
During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. | text | 96368 | sharesItemType | text: <entity> 96368 </entity> <entity type> sharesItemType </entity type> <context> During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. | text | 103465 | sharesItemType | text: <entity> 103465 </entity> <entity type> sharesItemType </entity type> <context> During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. | text | 112203 | sharesItemType | text: <entity> 112203 </entity> <entity type> sharesItemType </entity type> <context> During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. | text | 8.0 | monetaryItemType | text: <entity> 8.0 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding |
During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. | text | 16.6 | monetaryItemType | text: <entity> 16.6 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding |
During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. | text | 14.8 | monetaryItemType | text: <entity> 14.8 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding |
During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. | text | 8.9 | monetaryItemType | text: <entity> 8.9 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. | text | 8.4 | monetaryItemType | text: <entity> 8.4 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. | text | 6.3 | monetaryItemType | text: <entity> 6.3 </entity> <entity type> monetaryItemType </entity type> <context> During 2024, 2023 and 2022, we awarded 96,368 , 103,465 and 112,203 restricted shares, respectively, to our employees and directors. These awards had an aggregate value at their date of grant of $ 8.0 million, $ 16.6 million and $ 14.8 million, respectively, and were scheduled to vest over a period of up to four years . The fair value of restricted shares that vested during 2024, 2023 and 2022 was $ 8.9 million, $ 8.4 million and $ 6.3 million, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue |
As of December 31, 2024, there was $ 15.3 million of total future compensation cost related to unvested restricted share awards that are expected to vest. That cost is expected to be recognized over a weighted-average period of 2.21 years. | text | 15.3 | monetaryItemType | text: <entity> 15.3 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there was $ 15.3 million of total future compensation cost related to unvested restricted share awards that are expected to vest. That cost is expected to be recognized over a weighted-average period of 2.21 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions |
During 2024, 2023 and 2022, we granted awards to certain of our executive officers covering a total of 92,761 , 60,633 and 49,065 PSUs, respectively. The number of earned PSUs that ultimately vest over three years , following conclusion of the performance period, is determined based upon on achievement of specific financial or operational goals. The number of PSUs that can be earned, range from a minimum of 30 % of the PSU awards to a maximum of 200 % , of the PSUs granted. In addition to these PSUs, we also granted 5,356 performance share awards in 2024. The vesting of these awards is based upon achievement of financial milestones over specified time periods. | text | 92761 | sharesItemType | text: <entity> 92761 </entity> <entity type> sharesItemType </entity type> <context> During 2024, 2023 and 2022, we granted awards to certain of our executive officers covering a total of 92,761 , 60,633 and 49,065 PSUs, respectively. The number of earned PSUs that ultimately vest over three years , following conclusion of the performance period, is determined based upon on achievement of specific financial or operational goals. The number of PSUs that can be earned, range from a minimum of 30 % of the PSU awards to a maximum of 200 % , of the PSUs granted. In addition to these PSUs, we also granted 5,356 performance share awards in 2024. The vesting of these awards is based upon achievement of financial milestones over specified time periods. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During 2024, 2023 and 2022, we granted awards to certain of our executive officers covering a total of 92,761 , 60,633 and 49,065 PSUs, respectively. The number of earned PSUs that ultimately vest over three years , following conclusion of the performance period, is determined based upon on achievement of specific financial or operational goals. The number of PSUs that can be earned, range from a minimum of 30 % of the PSU awards to a maximum of 200 % , of the PSUs granted. In addition to these PSUs, we also granted 5,356 performance share awards in 2024. The vesting of these awards is based upon achievement of financial milestones over specified time periods. | text | 60633 | sharesItemType | text: <entity> 60633 </entity> <entity type> sharesItemType </entity type> <context> During 2024, 2023 and 2022, we granted awards to certain of our executive officers covering a total of 92,761 , 60,633 and 49,065 PSUs, respectively. The number of earned PSUs that ultimately vest over three years , following conclusion of the performance period, is determined based upon on achievement of specific financial or operational goals. The number of PSUs that can be earned, range from a minimum of 30 % of the PSU awards to a maximum of 200 % , of the PSUs granted. In addition to these PSUs, we also granted 5,356 performance share awards in 2024. The vesting of these awards is based upon achievement of financial milestones over specified time periods. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During 2024, 2023 and 2022, we granted awards to certain of our executive officers covering a total of 92,761 , 60,633 and 49,065 PSUs, respectively. The number of earned PSUs that ultimately vest over three years , following conclusion of the performance period, is determined based upon on achievement of specific financial or operational goals. The number of PSUs that can be earned, range from a minimum of 30 % of the PSU awards to a maximum of 200 % , of the PSUs granted. In addition to these PSUs, we also granted 5,356 performance share awards in 2024. The vesting of these awards is based upon achievement of financial milestones over specified time periods. | text | 49065 | sharesItemType | text: <entity> 49065 </entity> <entity type> sharesItemType </entity type> <context> During 2024, 2023 and 2022, we granted awards to certain of our executive officers covering a total of 92,761 , 60,633 and 49,065 PSUs, respectively. The number of earned PSUs that ultimately vest over three years , following conclusion of the performance period, is determined based upon on achievement of specific financial or operational goals. The number of PSUs that can be earned, range from a minimum of 30 % of the PSU awards to a maximum of 200 % , of the PSUs granted. In addition to these PSUs, we also granted 5,356 performance share awards in 2024. The vesting of these awards is based upon achievement of financial milestones over specified time periods. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During 2024, 2023 and 2022, we granted awards to certain of our executive officers covering a total of 92,761 , 60,633 and 49,065 PSUs, respectively. The number of earned PSUs that ultimately vest over three years , following conclusion of the performance period, is determined based upon on achievement of specific financial or operational goals. The number of PSUs that can be earned, range from a minimum of 30 % of the PSU awards to a maximum of 200 % , of the PSUs granted. In addition to these PSUs, we also granted 5,356 performance share awards in 2024. The vesting of these awards is based upon achievement of financial milestones over specified time periods. | text | 30 | percentItemType | text: <entity> 30 </entity> <entity type> percentItemType </entity type> <context> During 2024, 2023 and 2022, we granted awards to certain of our executive officers covering a total of 92,761 , 60,633 and 49,065 PSUs, respectively. The number of earned PSUs that ultimately vest over three years , following conclusion of the performance period, is determined based upon on achievement of specific financial or operational goals. The number of PSUs that can be earned, range from a minimum of 30 % of the PSU awards to a maximum of 200 % , of the PSUs granted. In addition to these PSUs, we also granted 5,356 performance share awards in 2024. The vesting of these awards is based upon achievement of financial milestones over specified time periods. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
During 2024, 2023 and 2022, we granted awards to certain of our executive officers covering a total of 92,761 , 60,633 and 49,065 PSUs, respectively. The number of earned PSUs that ultimately vest over three years , following conclusion of the performance period, is determined based upon on achievement of specific financial or operational goals. The number of PSUs that can be earned, range from a minimum of 30 % of the PSU awards to a maximum of 200 % , of the PSUs granted. In addition to these PSUs, we also granted 5,356 performance share awards in 2024. The vesting of these awards is based upon achievement of financial milestones over specified time periods. | text | 200 | percentItemType | text: <entity> 200 </entity> <entity type> percentItemType </entity type> <context> During 2024, 2023 and 2022, we granted awards to certain of our executive officers covering a total of 92,761 , 60,633 and 49,065 PSUs, respectively. The number of earned PSUs that ultimately vest over three years , following conclusion of the performance period, is determined based upon on achievement of specific financial or operational goals. The number of PSUs that can be earned, range from a minimum of 30 % of the PSU awards to a maximum of 200 % , of the PSUs granted. In addition to these PSUs, we also granted 5,356 performance share awards in 2024. The vesting of these awards is based upon achievement of financial milestones over specified time periods. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
During 2024, 2023 and 2022, we granted awards to certain of our executive officers covering a total of 92,761 , 60,633 and 49,065 PSUs, respectively. The number of earned PSUs that ultimately vest over three years , following conclusion of the performance period, is determined based upon on achievement of specific financial or operational goals. The number of PSUs that can be earned, range from a minimum of 30 % of the PSU awards to a maximum of 200 % , of the PSUs granted. In addition to these PSUs, we also granted 5,356 performance share awards in 2024. The vesting of these awards is based upon achievement of financial milestones over specified time periods. | text | 5356 | sharesItemType | text: <entity> 5356 </entity> <entity type> sharesItemType </entity type> <context> During 2024, 2023 and 2022, we granted awards to certain of our executive officers covering a total of 92,761 , 60,633 and 49,065 PSUs, respectively. The number of earned PSUs that ultimately vest over three years , following conclusion of the performance period, is determined based upon on achievement of specific financial or operational goals. The number of PSUs that can be earned, range from a minimum of 30 % of the PSU awards to a maximum of 200 % , of the PSUs granted. In addition to these PSUs, we also granted 5,356 performance share awards in 2024. The vesting of these awards is based upon achievement of financial milestones over specified time periods. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During 2024, 2023 and 2022, we granted awards for 52,930 , 29,621 and 47,622 TSR Shares, respectively, which are equity classified awards and will vest on our performance compared to our peer group over a three -year period. These awards had an aggregate fair value at their date of grant of $ 4.3 million, $ 2.5 million and $ 2.3 million, respectively, after consideration of all assumptions. | text | 52930 | sharesItemType | text: <entity> 52930 </entity> <entity type> sharesItemType </entity type> <context> During 2024, 2023 and 2022, we granted awards for 52,930 , 29,621 and 47,622 TSR Shares, respectively, which are equity classified awards and will vest on our performance compared to our peer group over a three -year period. These awards had an aggregate fair value at their date of grant of $ 4.3 million, $ 2.5 million and $ 2.3 million, respectively, after consideration of all assumptions. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During 2024, 2023 and 2022, we granted awards for 52,930 , 29,621 and 47,622 TSR Shares, respectively, which are equity classified awards and will vest on our performance compared to our peer group over a three -year period. These awards had an aggregate fair value at their date of grant of $ 4.3 million, $ 2.5 million and $ 2.3 million, respectively, after consideration of all assumptions. | text | 29621 | sharesItemType | text: <entity> 29621 </entity> <entity type> sharesItemType </entity type> <context> During 2024, 2023 and 2022, we granted awards for 52,930 , 29,621 and 47,622 TSR Shares, respectively, which are equity classified awards and will vest on our performance compared to our peer group over a three -year period. These awards had an aggregate fair value at their date of grant of $ 4.3 million, $ 2.5 million and $ 2.3 million, respectively, after consideration of all assumptions. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
During 2024, 2023 and 2022, we granted awards for 52,930 , 29,621 and 47,622 TSR Shares, respectively, which are equity classified awards and will vest on our performance compared to our peer group over a three -year period. These awards had an aggregate fair value at their date of grant of $ 4.3 million, $ 2.5 million and $ 2.3 million, respectively, after consideration of all assumptions. | text | 47622 | sharesItemType | text: <entity> 47622 </entity> <entity type> sharesItemType </entity type> <context> During 2024, 2023 and 2022, we granted awards for 52,930 , 29,621 and 47,622 TSR Shares, respectively, which are equity classified awards and will vest on our performance compared to our peer group over a three -year period. These awards had an aggregate fair value at their date of grant of $ 4.3 million, $ 2.5 million and $ 2.3 million, respectively, after consideration of all assumptions. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
As of December 31, 2024, there was $ 2.7 million of total future compensation cost related to unvested TSR Share awards. The TSR Shares will amortize over a weighted average remaining period of 1.67 years. | text | 2.7 | monetaryItemType | text: <entity> 2.7 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there was $ 2.7 million of total future compensation cost related to unvested TSR Share awards. The TSR Shares will amortize over a weighted average remaining period of 1.67 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.